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Xue-Jun Zhang2, Wanling Yang1,18 and Yu Lung Lau1*Abstract
Introduction: Systemic lupus erythematosus (SLE) is a heterogeneous disease with a diverse spectrum of clinical
symptoms, ranging from skin rash to end-organ damage. 22q11.21 has been identified as a susceptibility region for
several autoimmune diseases, including SLE. However, detailed information for SLE association and the underlying
functional mechanism(s) is still lacking.
Methods: Through meta-analysis of two genome-wide association studies (GWAS) on Han Chinese populations,
comprising a total of 1,659 cases and 3,398 controls matched geographically, we closely examined the 22q11.21
region, especially on the reported single-nucleotide polymorphisms (SNPs) associated with different autoimmune
diseases and their relationships. We further replicated the most significant associations of SNPs with SLE using 2,612
cases and 2,323 controls of Asian ancestry.
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Results: All reported SNPs in the 22q11.21 region with different autoimmune diseases were examined using the
two GWAS data and meta-analysis results, and supportive evidence of association with SLE was found (meta-analysis:
P_meta ≤ 7.27E-05), which might require further investigation. SNP rs2298428 was identified as the most significant SNP
associated with SLE in this region (P_meta =2.70E-09). It showed independent effects through both stepwise and
conditional logistic regression, and there is no evidence of other independent association signals for SLE in this
region. The association of rs2298428 was further replicated in three cohorts from Hong Kong, Anhui and Thailand
comprising a total of 2,612 cases and 2,323 controls (joint analysis of GWAS and replication result: P_all =1.31E-11,
odds ratio =1.23). SNP rs2298428 was shown to be an expression quantitative locus for UBE2L3 gene in different
cell types, with the risk allele (T) being correlated with higher expression of UBE2L3. This is consistent with earlier
reports on higher expression of UBE2L3 in patients with SLE.
Conclusions: Association with distinct autoimmune diseases highlights the significance of this region in
autoreactive responses and potentially shared functional mechanisms in these diseases.Introduction
Systemic lupus erythematosus (SLE) is an autoimmune
disease with an unclear etiology. It usually presents with
a diverse spectrum of clinical manifestation spanning from
malar rash to kidney injury. Genetic factors explain about
50% to 60% of the disease etiology [1]. The concordance
rate for SLE is much higher in monozygotic (25% to 70%)
than in dizygotic (2% to 9%) twins [2,3], indicating the im-
portance of genetic contributions.
In genome-wide association studies (GWAS) on SLE,
researchers have identified more than 40 loci associated
with the disease [4-16]. Many regions, such as STAT4,
BLK and IRF5, were found to modulate risk of multiple
diseases, although the causal variant(s) may not be shared
by different diseases [17]. Cotsapas et al. [17] estimated
that 44% of single-nucleotide polymorphisms (SNPs) asso-
ciated with one autoimmune disease might also be associ-
ated with another one. These observations support the
hypothesis that autoimmune diseases may share common
genetic basis.
The 22q11.21 genomic region was found to be associ-
ated with multiple autoimmune diseases, including SLE
[14,18], systemic sclerosis (SSc) [19], Crohn’s disease
(CD) [20], celiac disease (CeD) and rheumatoid arthritis
(RA) [21], psoriasis (PS) [22] and inflammatory bowel
disease (IBD) [23]. SNP rs5754217-A (denoting risk al-
lele A of rs5754217), located in the intron of UBE2L3,
showed a suggestive association with SLE in women of
European ancestry (P = 7.53 × 10−8) [18]. SNP rs463426-
A and rs131654-A, located downstream of HIC2 and
upstream of UBE2L3, was identified as susceptibility
variants with SLE in a Han Chinese population (P =
1.48 × 10−16 and 2.99 × 10−16, respectively) [14]. SNP
rs2298428-T, which is a missense variant in YDJC, was
significantly enriched in diffuse SSc, though no inde-
pendent study showed the variant reaching GWAS
significance (P =0.017) [19]. SNP rs2298428-T was also
suggested to be associated with CD (P = 5.22 × 10−5)[20]. The same SNP was also reported to be associated
with both CeD and RA (rs2298428-T, P = 2.5 × 10−10)
[21]. Another SNP, rs181359-A, located in intron 2 of
UBE2L3, was established as associated with PS and CD
(P = 8.02 × 10−10, P = 6.3 × 10−13, respectively) [22]. SNP
rs2266959-T, also located in intron 2 of UBE2L3, was
also robustly associated with IBD (P = 1 × 10−16) [23]. Des-
pite the various reports on this region, the details of
association and potential independent effects are unclear.
Further elucidation of the signals in this region may help
improve understanding of the shared etiological basis
among autoimmune and inflammatory diseases.
In the present study, we examined the association for
SLE in the 22q11.21 region and further replicated the as-
sociation of SNP rs2298428 in a total of 4,271 cases and
5,721 controls of Asian ancestry. To that end, our results
confirmed rs2298428 as the most significant SNP associ-
ated with SLE in this region. Meanwhile, the risk allele
of this SNP is highly correlated with higher expression
of UBE2L3 in different cell lines.
Methods
Study participants
The samples included in the present study were col-
lected from Hong Kong and Anhui, China, and from
Bangkok, Thailand (Additional file 1). All the cases ful-
filled the revised criteria of the American College of
Rheumatology for diagnosis of SLE. Cases from Hong
Kong were recruited from five hospitals in Hong Kong:
Queen Mary Hospital, Tuen Mun Hospital, Queen
Elizabeth Hospital, Pamela Youde Nethersole Eastern
Hospital and Princess Margaret Hospital (HK_GWAS
and HK_REP). Clinical records were well documented
with autoantibody profiles and subphenotypes. Controls
from Hong Kong were individuals from other GWAS
studies who had no overlapping manifestations with SLE
in the discovery stage (HK_GWAS). Cases from Anhui
were patients visiting the Department of Rheumatology at
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of Anhui Medical University in Hefei, Anhui province
(AH_REP), with corresponding controls from healthy
blood donors in Anhui (AH_REP). The cases for the
Anhui GWAS (AH_GWAS) were recruited from several
hospitals in central and southern China, and the controls
were carefully selected with geographically matched and
clinically unrelated individuals (AH_GWAS). The cases
from Thailand were patients at King Chulalongkorn
Memorial Hospital (TH_REP), and geographically matched
healthy donors were used as controls (TH_REP). All the
individuals involved in the present study gave informed
consent. The study conducted in Hong Kong was approved
by the institutional review board of the University of Hong
Kong/Hospital Authority Hong Kong West Cluster. The
study in Anhui was approved by the institutional review
board of Anhui Medical University. The Thailand
study was approved by the intuitional review board of
the Faculty of Medicine, Chulalongkorn University,
Bangkok, Thailand.
Imputation
IMPUTE2.3.1 was used to perform imputation on the
Hong Kong and Anhui data by using all the samples from
1000 Genome Project (released in September 2013). SNPs
that violated Hardy-Weinberg equilibrium (HWE) and
SNPs with minor allele frequency <0.05% were removed
for further analysis.
Genotyping
The GWAS on the Hong Kong and Anhui cohorts were
conducted using the Illumina Human610-Quad BeadChip
array (Illumina, San Diego, CA, USA), as previously re-
ported (HK_GWAS and AH_GWAS). Further replication
of the candidate SNPs was performed by using the Taq-
Man genotyping method (Life Technologies, Carlsbad,
CA, USA) with the remaining samples from the Hong
Kong cohort that were not included in the discovery stage
(HK_REP); samples collected from Bangkok, Thailand
(TH_REP); and samples from an independent Anhui
cohort (AH_REP). Genotyping concordance between
Illumina Human610-Quad BeadChip and TaqMan SNP
genotyping method was also checked on randomly se-
lected samples, and the two methods showed complete
concordance.
Association analysis
We used inverse variance method for the meta-analysis
installed in METAL [24]. Joint analysis of association
was conducted using the Cochran-Mantel-Haenszel
(CMH) test, taking into account the effect of SNP differ-
ences between cohorts. The homogeneity of the effect
size between different cohorts and different stages of thestudy was evaluated by using the Breslow-Day test
(P_het in Table 1), both installed in PLINK 1.07.
Stepwise logistic regression was performed using IBM
SPSS 16.0 software (IBM, Armonk, NY, USA). Tests of
independent contributions toward disease associations
for SNPs in a single locus were done using logistic re-
gression, adjusting for the effect of a specific SNP in the
same locus, while also taking into account differences
among cohorts. SNPTEST v2.2.0 was used to perform the
logistic regression tests in this study [25]. Linkage dis-
equilibrium (LD) patterns and values were obtained
using Haploview [26].
Results
Imputation and meta-analysis of two genome-wide
association studies on Han Chinese populations from
Hong Kong and Anhui
First, imputation was performed using IMPUTE2 [27]
on two GWAS on Han Chinese populations. Association
analysis was performed using SNPTEST v2.2.0, taking
the genotype uncertainty into account. Meta-analysis was
performed using METAL [24] with the inverse variance-
based model. We examined the meta-analysis results in
22q11.21 and observed a total of 4,834 SNPs in this 1.9-Mb
region, from 20,220,110 to 22,131,990 bp (GRCh37/hg19).
On the basis of meta-analysis P-values (P_meta), 121 SNPs
showed suggestive associations (P_meta <0.0001), aggregat-
ing in a 187-kb region (Additional file 2). SNP rs2298428
showed the most significant P-value (P_meta =2.70E-
09). Of the 96 SNPs, 25 SNPs had P_meta-values reach-
ing genome-wide significance (5E-08), including SNP
rs2298428. The other 24 SNPs all had high LD with
rs2298428 (r2 > 0.9).
Linkage disequilibrium pattern of single-nucleotide
polymorphisms in 22q11.21 associated with
immune-related diseases
For the purpose of finding potentially shared susceptible
variants and/or causal variants between SLE and other
immune-related diseases, we focused on SNP rs2298428,
which showed the most significant P-values for SLE in our
meta-analysis results, and other reported SNPs in this re-
gion that showed association with SLE (rs5754217,
rs463426 and rs131654) [14,18], CD and PS (rs181359)
[22], and IBD (rs2266959). SNP rs2298428 was also re-
ported to be associated with other immune-related dis-
eases, including SSc [19], CeD and RA [21]. As shown
in Table 2, all six SNPs reported for different diseases
showed strong evidence of association with SLE in
Asian populations (2.70E-09 ≤ − ≤ 7.27E-05). The LD
patterns of these six SNPs are shown in Figure 1, based
on different populations from HapMap data including
Han Chinese, Beijing, population and Utah residents
with ancestry from northern and western Europe (CHB
Table 1 Association results of single-nucleotide polymorphism rs2298428 from each cohort and joint analysisa
SNP Gene/AA
change
HK (HK_GWAS +
HK_REP)
AH (AH_GWAS +
AH_REP)
TH_REP Combination
F_A F_U P-value OR F_A F_U P-value OR F_A F_U P-value OR P_all OR_all (CMH test) P_het
rs2298428 YDJC/Ala263Thr 0.50 0.46 1.71E-03 1.17 0.44 0.37 3.16E-09 1.29 0.49 0.45 0.06 1.16 1.31E-11 1.23 (1.16 to 1.30) 0.26
aAA, Amino acid; AH, Anhui; AH_GWAS + AH_REP, Cases from Anhui were patients visiting the Department of Rheumatology at Anhui Provincial Hospital and the
First Affiliated Hospital of Anhui Medical University in Hefei, Anhui province (AH_REP), with corresponding controls from healthy blood donors in Anhui (AH_REP).
The cases for the Anhui GWAS (AH_GWAS) were recruited from several hospitals in central and southern China, and the controls were carefully selected with
geographically matched and clinically unrelated individuals (AH_GWAS); GWAS, Genome-wide association studies; HK, Hong Kong; HK_GWAS + HK_REP, Cases
from five hospitals in Hong Kong: Queen Mary Hospital, Tuen Mun Hospital, Queen Elizabeth Hospital, Pamela Youde Nethersole Eastern Hospital and Princess
Margaret Hospital; TH_REP, Cases from Thailand were patients at King Chulalongkorn Memorial Hospital. F_A/F_U indicates minor allele frequency of the
single-nucleotide polymorphism (SNP) in cases or controls. The calculation of odds ratio (OR) is also based on the minor allele of each SNP.
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(AH). The LD patterns in CHB, HK and AH populations
were similar. In these three Chinese populations, all but
rs463426 showed moderate to high LD between each
other (r2 > 0.5). We also compared the LD patterns be-
tween the Chinese populations and CEU (Figure 1). In
Caucasians, SNPs rs463426 and rs131654 showed min-
imal LD with all the other SNPs (r2 < 0.2). The other
four SNPs showed high LD with each other (r2 > 0.95).
Independence test on the single-nucleotide polymor-
phisms associated with immune-related diseases
A stepwise logistic regression analysis was performed to
test the independence of these SNPs (Table 3). The method
begins with an empty model, to which the variables were
added one at a time. The analysis showed that SNP
rs2298428 exhibited the strongest, and the only, significant
association with SLE. Further addition of any other SNPs
involved did not show significant improvement of the
model, which is partially explained by the high LD among
most of these SNPs. However, the SNPs with moderate LD
did not show significant improvement in the model, dem-
onstrating a lack of evidence of further independent signals
of association for SLE in this region.
Conditional logistic regression analysis was performed
to investigate the independent effects among these repli-
cated SNPs with immune-related diseases (Table 4). SNPTable 2 Meta-analysis results for single-nucleotide polymorph
studies on other immune-related diseases in the 22q11.21 re
G/
I
SNP Base pair A1/A2 AH
F_A/F_U P-value OR (95% CI)
G rs463426 21,809,185 C/T 0.46/0.53 3.62E-05 0.78 (0.70 to 0.88)
G rs131654 21,917,190 G/T 0.41/0.48 1.60E-05 0.77 (0.69 to 0.87)
I rs2266959 21,922,904 T/G 0.45/0.37 3.22E-07 1.37 (1.21 to 1.54)
I rs181359 21,928,641 A/G 0.53/0.46 1.86E-06 1.33 (1.18 to 1.50)
G rs5754217 21,939,675 T/G 0.53/0.46 1.04E-06 1.34 (1.19 to 1.51)
G rs2298428 21,982,892 T/C 0.44/0.37 4.72E-07 1.37 (1.21 to 1.54)
aAH, Anhui; CeD, Celiac disease; CS, Crohn’s disease; CI, Confidence interval; HK, Hon
arthritis; SSc, Systemic sclerosis; SLE, Systemic lupus erythematosus. G/I indicates wh
(I). A1/A2 indicates the minor allele/major allele of the SNP. F_A/F_U indicates mino
(OR) is also based on the minor allele of each SNP. The risk allele of each SNP is itars2298428 remained significant when the effect of any
other SNPs was accounted for, except for SNP rs2266959.
More intuitively, the association P-values of all SNPs be-
fore and after the effect of rs2298428 was adjusted for are
shown in Figure 2.Replication on single-nucleotide polymorphism
rs2298428
Replication for SNP rs2298428 was performed by using
a TaqMan SNP genotyping method (Life Technologies)
on the Hong Kong cohort independent from Hong
Kong samples genotyped in the GWAS stage; samples
collected from Bangkok, Thailand; and samples from
Anhui, China, which were independent from the Anhui
GWAS cohort. As shown in Table 5, replications in dif-
ferent cohorts showed consistent results as those from
the discovery stage (Table 1). The joint analysis of asso-
ciation, taking into account the effect of SNP differences
among cohorts from Hong Kong, Anhui and Thailand
from both discovery stage and replication stage, was
conducted using the Cochran-Mantel-Haenszel test. SNP
rs2298428 showed stronger evidence of association with
SLE (P =1.31E-11), and testing of between-population
heterogeneity of odds ratios by the Breslow-Day test did
not show significant differences among the cohorts
(P_het =0.26).isms reported in previous genome-wide association
giona
HK P_meta-
value
P_het-
value
Disease(s)
F_A/F_U P-value OR (95% CI)
0.42/0.45 0.08 0.89 (0.79 to 1.02) 2.50E-05 0.14 SLE
0.38/0.40 0.24 0.93 (0.81 to 1.05) 7.27E-05 0.04 SLE
0.52/0.47 1.66E-03 1.22 (1.07 to 1.38) 4.41E-09 0.27 IBD
0.58/0.56 0.07 1.12 (0.99 to 1.28) 2.36E-06 0.06 PS, CD
0.59/0.56 0.09 1.12 (0.98 to 1.27) 2.07E-06 0.04 SLE
0.51/0.46 8.44E-04 1.24 (1.09 to 1.40) 2.70E-09 0.36 CD, CeD,
RA, SSc
g Kong; IBD, Inflammatory bowel disease; PS, Psoriasis; RA, Rheumatoid
ether the single-nucleotide polymorphism (SNP) are genotyped (G) or imputed
r allele frequency of the SNP in cases or controls. The calculation of odds ratio
lics.
Figure 1 The linkage disequilibrium patterns of the susceptibility single-nucleotide polymorphisms for autoimmune diseases in
different populations. AH, Anhui; CeD, Celiac disease; CEU, Utah residents with ancestry from northern and western Europe; CHB, Han Chinese,
Beijing; HK, Hong Kong; IBD, Inflammatory bowel disease; PS, Psoriasis; RA, Rheumatoid arthritis; SLE, Systemic lupus erythematosus.
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Expression quantitative trait loci (eQTL) associations be-
tween SNP rs2298428 and UBE2L3 and other genes in
this region were closely examined. Two datasets, from
Stranger et al. [28] and Fairfax et al. [29], were investi-
gated. In the first study, the researchers examined the
correlation of SNPs to gene expression using the lym-
phoblastoid cell lines (LCLs) of 726 individuals in 8Table 3 Independent effects among the single-nucleotide
polymorphisms in the 22q11.21 regiona
SNP added to the model P-value OR (95% CI)
rs463426 0.76 –
rs131654 0.47 –
rs2266959 0.46 –
rs181359 0.31 –
rs5754217 0.36 –
rs2298428 2.48E-08 1.29 (1.18 to 1.41)
aCI, Confidence interval; OR, Odds ratio; SNP, Single-nucleotide polymorphism.cohorts from the HapMap3 project. In the second study,
the investigators assessed the correlation of SNPs to gene
expression in a cell-specific manner using 288 paired,
purified primary monocytes and B cells from Caucasians.
As shown in Table 5, the genotype of SNP rs2298428 cor-
related with expression of UBE2L3 in five different popu-
lations. (The other three cohorts did not show significant
correlation, possibly due to the low frequency of the al-
ternative allele, thus lower power.) The genotypes of the
SNP also significantly correlated with the expression of
UBE2L3 in B cells and monocytes. The results consist-
ently demonstrated that the risk allele T from rs2298428
is correlated with higher expression of UBE2L3.
The gene expression pattern of UBE2L3 was also ex-
amined using a publicly available database, NextBio [30]
(Additional file 3). Five independent studies reported
increased expression of UBE2L3 from patients with
lupus compared with healthy controls in different cell
lines. In addition, UBE2L3 was found to have increased
expression in a number of other autoimmune diseases,
including CD, T1D, SS, PS and PA, using the same
Table 4 Conditional logistic regression analysisa
SNP whose effect is adjusted for
rs463426 rs131654 rs2266959 rs181359 rs5754217 rs2298428
rs463426 OR (95% CI) 1.14 (1.01 to 1.27) 1.02 (0.91 to 1.14) 1.1 (0.98 to 1.23) 1.09 (0.98 to 1.23) 1.05 (0.94 to 1.17)
P-value 0.03 0.74 0.12 0.12 0.39
rs131654 OR (95% CI) 1.10 (0.98 to 1.24) 0.95 (0.82 to 1.10) 0.99 (0.81 to 1.21) 0.94 (0.77 to 1.15) 0.96 (0.85 to 1.10)
P-value 0.09 0.51 0.92 0.57 0.59
rs2266959 OR (95% CI) 1.27 (1.14 to 1.43) 1.33 (1.16 to 1.53) 1.37 (1.15 to 1.63) 1.36 (1.14 to 1.62) 0.79 (0.43 to 1.45)
P-value 3.02E-05 4.36E-05 4.69E-04 5.21E-04 0.44
rs181359 OR (95% CI) 1.16 (1.04 to 1.30) 1.25 (1.03 to 1.52) 0.92 (0.77 to 1.11) 0.17 (0.01 to 3.89) 0.98 (0.83 to 1.14)
P-value 8.88E-03 0.02 0.39 0.27 0.76
rs5754217 OR (95% CI) 1.17 (1.04 to 1.31) 1.3 (1.08 to 1.57) 0.93 (0.77 to 1.11) 0.94 (0.77 to 1.11) 0.98 (0.84 to 1.14)
P-value 7.21E-03 6.75E-03 0.41 0.20 0.79
rs2298428 OR (95% CI) 1.27 (1.14 to 1.41) 1.33 (1.18 to 1.51) 1.61 (0.87 to 2.95) 1.31 (1.13 to 1.53) 1.32 (1.13 to 1.53)
P-value 1.61E-05 7.08E-06 0.13 5.14E-04 3.32E-04
aCI, Confidence interval; OR, Odds ratio; SNP, Single-nucleotide polymorphism. Independence tests were performed using the two genome-wide association
datasets. Conditional P-values <0.05 are shown in bold.
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player in disease association of this region.
Discussion
In this study, through meta-analysis of two existing
GWAS on Han Chinese populations with a total numberFigure 2 Association P-values of all single-nucleotide polymorphisms
graph depicts the association P-values of all single-nucleotide polymorphis
disequilibrium (LD) between the SNPs and SNP rs2298428, using hg19/100
adjustment for the effect of rs2298428. The arrows show the reduction of tof 1,659 cases and 3,398 controls matched geographic-
ally, we identified SNP rs2298428 as the SNP with the
highest association with SLE in the 22q11.21 region
(P_meta =2.70E-09). The association of rs2298428 was
further supported by replication in three cohorts from
Hong Kong, Anhui and Thailand, and the resultsbefore and after adjustment for the effect of rs2298428. The
ms (SNPs) before (the gradient colors of dots reflects the linkage
0 Genomes March 2012 ASN (Asian) as a reference) and after (gray)
he SNPs after the association adjusted by the effect of rs2298428.
Table 5 The expression quantitative trait loci evidence on the single-nucleotide polymorphism rs2298428 on systemic
lupus erythematosus and other immune-related diseasesa
SNP UBE2L3
HapMap_LCL B cell Monocyte
CEU CHB GIH JPT LWK MEX MKK YRI
rs2298428 0.0012 0.0136 0.0158 9.4E-06 – 0.0047 – – 1.3E-05 9.6E-15
aAH, Anhui; CEU, Utah residents with ancestry from northern and western Europe; CHB, Han Chinese in Bejing, China; GIH, Gujarati Indian from Houston, Texas;JPT,
Japanese in Tokyo, Japan; LWK,Luhya in Webuye, Kenya; MEX,Mexican ancestry in Los Angeles, California; MKK,Maasai in Kinyawa, Kenya; YRI,Yoruba in Ibadan,
Nigeria; LCL, Lymphoblastoid cell line; SNP, Single-nucleotide polymorphism.
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lysis from the discovery stage and the replication stage
(P_all =1.31E-11, odds ratio =1.23).
Many GWAS hits were aggregated in this region for
different autoimmune diseases, and here we tried to find
out whether all the reported SNPs (six SNPs included)
were linked to the same causal variant or whether they
were derived from independent signals. All of the SNPs
showed strong evidence of association with SLE in the
current investigation with P_meta <7.27E-05. Stepwise lo-
gistic regression and conditional logistic regression were
performed to examine the independence of these SNPs.
The results supported the notion that rs2298428 exhibited
the strongest association with SLE. According to the LD
pattern, SNP rs463426 is relatively independent from the
other five SNPs (Figure 1). However, we were unable to
find evidence of independence based on the presently re-
ported results (Figure 2). This might be due to the fact
that the exploration of independently contributing vari-
ants from this region is based mainly on the meta-analysis
data, which might not have enough power to detect
multiple independent signals. The five SNPs reported
for different autoimmune diseases are located in the
same LD block in Chinese population, and their associ-
ation may be derived from the same casual variant. These
cross-phenotype associations in this region highlighted
the shared genetic involvement in autoimmune diseases.
In addition, to identify how this region might influence
susceptibility to SLE and other autoimmune diseases, we
investigated the potential biological function of the gene.
eQTL analysis is an important approach in detecting
functional mechanisms underlying association by testing
whether identified variants may lead to variations in
mRNA expression of nearby genes. Using publicly avail-
able eQTL datasets, the SNPs in the 22q11.21 region
were analyzed. All the results pointed to increased expres-
sion of UBE2L3 as the mechanism for association with
SLE. UBE2L3 encodes a member of the E2 ubiquitin-
conjugating enzyme family. This enzyme was demon-
strated to participate in the ubiquitination of p53, c-Fos
and the nuclear factor κB precursor p105 in vitro [31,32].
There is also evidence showing the interaction between
UBE2L3 and RNF125 [33]. RNF125 is reported as a nega-
tive regulator of type I interferon (IFN) signaling. It is wellknown that patients with SLE have elevated serum levels
of type I IFN [34] and that these increased levels correlate
with disease activity and severity [35]. Among numerous
immunologic alterations present in patients with lupus,
the type I IFN system is thought to play a pivotal role in
pathogenesis [36-38], which points to a possible role of
UBE2L3. However, the exact mechanism of UBE2L3 is still
not fully understood.
Conclusions
Focusing on the SNPs in 22q11.21 region with strong evi-
dence of being associated with SLE in previous work, we
have identified one more novel susceptibility variant show-
ing the most significant genetic contribution for SLE via
meta-analysis and further replication in independent co-
horts. The putative susceptibility gene, UBE2L3, is sug-
gested to be related to the type I IFN signaling pathway in
SLE pathogenesis. Our findings may shed light on the
shared biological mechanisms between different dis-
eases with immunological components.
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